Table 2.
The bilirubin levels in two groups of phototherapy and phototherapy + concentrated pomegranate juice
| Bilirubin level assessment (mg/dL), (n), mean±SD | Phototherapy | Phototherapy + CPJ | P a | P b |
|---|---|---|---|---|
| At the time of hospitalization | 17.61±2.54 (n=43) | 18.01±2.08 (n=43) | 0.487 | 0.005 |
| After hospitalization (h) | ||||
| 12 | 13.79±1.78 (n=43) | 14.15±1.71 (n=43) | 0.338 | |
| 24 | 11.99±2.06 (n=43) | 11.85±1.38 (n=43) | 0.486 | |
| 36 | 10.88±1.71 (n=41) | 10.19±1.38 (n=41) | 0.106 | |
| 48 | 10.49±1.49 (n=30) | 9.66±1.03 (n=23) | 0.048 | |
| 60 | 11.06±1.56 (n=22) | 9.36±1.28 (n=17) | 0.003 | |
| At discharge time | 9.33±1.00 (n=43) | 9.27±0.88 (n=43) | 0.758 | 0.003 |
| 48 h after discharge | 10.87±2.38 (n=43) | 9.41±1.68 (n=43) | 0.003 |
aUsing EM means of the GEE post hoc tests; bBetween-group comparison with GEE analysis. Significant P values are shown as bold text. CPJ=Concentrated pomegranate juice; SD=Standard deviation; GEE=Generalized estimating equations; EM=Expectation–Maximization